Cargando…

Uveal melanoma: progress in molecular biology and therapeutics

Uveal melanoma (UM) is the most common intraocular malignancy in adults. So far, no systemic therapy or standard treatment exists to reduce the risk of metastasis and improve overall survival of patients. With the increased knowledge regarding the molecular pathways that underlie the oncogenesis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yongyun, Shi, Jiahao, Yang, Jie, Ge, Shengfang, Zhang, Jianming, Jia, Renbing, Fan, Xianqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586035/ https://www.ncbi.nlm.nih.gov/pubmed/33149769 http://dx.doi.org/10.1177/1758835920965852

Ejemplares similares

Role of Epigenetics in Uveal Melanoma
por: Li, Yongyun, et al.
Publicado: (2017)

SKP2 targeted inhibition suppresses human uveal melanoma progression by blocking ubiquitylation of p27
por: Zhao, Hongbo, et al.
Publicado: (2019)

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression
por: Lu, Linna, et al.
Publicado: (2017)

Epigenetic drug library screening reveals targeting DOT1L abrogates NAD(+) synthesis by reprogramming H3K79 methylation in uveal melanoma
por: Gu, Xiang, et al.
Publicado: (2023)

Publication trends of research on uveal melanoma during 2000–2020: a 20-year bibliometric study
por: Xie, Minyue, et al.
Publicado: (2020)

The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma
por: Zhang, Leilei, et al.
Publicado: (2018)

Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
por: Ding, Yi, et al.
Publicado: (2021)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022)

Targeted Silencing of MART-1 Gene Expression by RNA Interference Enhances the Migration Ability of Uveal Melanoma Cells
por: Zhang, Yidan, et al.
Publicado: (2013)

Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells
por: He, Jie, et al.
Publicado: (2018)

An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma
por: Wen, Xuyang, et al.
Publicado: (2020)

Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma
por: Yu, Jie, et al.
Publicado: (2021)

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis
por: Chai, Peiwei, et al.
Publicado: (2020)

Therapeutic Efficacy by Targeting Correction of Notch1-Induced Aberrants in Uveal Tumors
por: Huang, Xiaolin, et al.
Publicado: (2012)

The Pharmacological NF-κB Inhibitor BAY11-7082 Induces Cell Apoptosis and Inhibits the Migration of Human Uveal Melanoma Cells
por: Hu, Shuiqing, et al.
Publicado: (2012)

Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m(6)A RNA methylation in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2023)

Xanthatin Selectively Targets Retinoblastoma by Inhibiting the PLK1-Mediated Cell Cycle
por: Yang, Jie, et al.
Publicado: (2021)

Sperm-Specific Glycolysis Enzyme Glyceraldehyde-3-Phosphate Dehydrogenase Regulated by Transcription Factor SOX10 to Promote Uveal Melanoma Tumorigenesis
por: Ding, Xia, et al.
Publicado: (2021)

Early Reconstruction Surgery Resolving Visual Occlusion and Ocular Malformation: A Case Report
por: Xu, Shiqiong, et al.
Publicado: (2014)

m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation
por: Jia, Ruobing, et al.
Publicado: (2019)

Long Non-coding RNA LINC-PINT Suppresses Cell Proliferation and Migration of Melanoma via Recruiting EZH2
por: Xu, Yangfan, et al.
Publicado: (2019)

A Novel Stimuli‐Responsive Injectable Antibacterial Hydrogel to Achieve Synergetic Photothermal/Gene‐Targeted Therapy towards Uveal Melanoma
por: Wang, Shaoyun, et al.
Publicado: (2021)

CDC20 Knockdown and Acidic Microenvironment Collaboratively Promote Tumorigenesis through Inhibiting Autophagy and Apoptosis
por: Gu, Qingying, et al.
Publicado: (2020)

LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020)

A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3
por: He, Xiaoyu, et al.
Publicado: (2020)

Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology
por: Lin, Huimin, et al.
Publicado: (2021)

Metformin promotes histone deacetylation of optineurin and suppresses tumour growth through autophagy inhibition in ocular melanoma
por: Zhuang, Ai, et al.
Publicado: (2022)

Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression
por: Gu, Xiang, et al.
Publicado: (2020)

Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy
por: Yu, Yilin, et al.
Publicado: (2023)

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
por: Vivet-Noguer, Raquel, et al.
Publicado: (2019)

The biology of uveal melanoma
por: Amaro, Adriana, et al.
Publicado: (2017)

Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment
por: Shi, Yingyun, et al.
Publicado: (2017)

Molecular Bases of Cutaneous and Uveal Melanomas
por: Gaudi, Sudeep, et al.
Publicado: (2011)

Research Progress of Cancer Stem Cells in Uveal Melanoma
por: Chen, Yu Ning, et al.
Publicado: (2020)

Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis
por: Pan, Hui, et al.
Publicado: (2020)

Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
por: Hua, Yu, et al.
Publicado: (2023)

Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway
por: Bao, Keting, et al.
Publicado: (2021)

Molecular characteristics of uveal melanoma and intraocular tumors
por: Katopodis, Periklis, et al.
Publicado: (2021)

Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape
por: Kong, Yuxin, et al.
Publicado: (2023)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1m06i2hj0cubj8p5jp2rf0dgaj